Glaukos Corporation (GKOS) is a medical technology company specializing in innovative devices and therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company is renowned for its minimally invasive surgical devices that revolutionize how glaucoma is managed, offering effective solutions with fewer complications than traditional methods.
Glaukos also focuses on developing pharmaceuticals for corneal health and retinal conditions, further broadening its impact on eye care. One of Glaukos’s key offerings is the iStent family of products, a series of tiny, implantable devices that help manage intraocular pressure (IOP) in patients with glaucoma. These devices have transformed the treatment of the disease by providing safer, long-term solutions.
The company is also advancing treatments for keratoconus, a progressive eye condition, and investing in pharmaceutical research for retinal diseases. Glaukos’s growth is driven by an aging global population and the rising prevalence of eye conditions, creating demand for innovative and effective treatments. By combining groundbreaking technology with a focus on improving patients’ quality of life, Glaukos remains a leader in ophthalmic care.
For more information about Glaukos Corporation and its groundbreaking eye health solutions, visit their main website.
Click The Image For Current Live Chart